Cannabis Indica

thcscience_admin
BFAI
Clinical data
ATC code
  • none
Identifiers
  • 6,7-dihydro-5H-cyclopenta[f][1]benzofuran-6-amine
PubChem CID
Chemical and physical data
FormulaC11H11NO
Molar mass173.215 g·mol−1
3D model (JSmol)
  • C1C(CC2=C1C=C3C=COC3=C2)N
  • InChI=1S/C11H11NO/c12-10-4-8-3-7-1-2-13-11(7)6-9(8)5-10/h1-3,6,10H,4-5,12H2
  • Key:SYCRQDBZPIEBIR-UHFFFAOYSA-N

BFAI (5,6-Benzofuranyl-2-aminoindane) is a drug that acts as a serotonin releasing agent (SSRA) and produces entactogen effects in humans, which may be useful for psychotherapeutic applications. It is closely related to MDAI but with the benzodioxole ring system replaced by benzofuran.[1]

See also[edit]

References[edit]

  1. ^ WO 2022/032147, Baggott M, "2-Aminoindane compounds for mental disorders or enhancement.", published 10 February 2022, assigned to Tactogen Inc. 
source: https://en.wikipedia.org/wiki/BFAI

Leave a Reply